Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in normal and malignant human prostate

Prostate

Volumn 33, Issue 2, 1997, Pages 133-140

  Perry, Kent T ^a   Anthony, Catherine T ^a   Steiner, Mitchell S ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

Prostate cancer; Transforming growth factor ; Tumor markers

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROTEIN DETERMINATION; PROTEIN LOCALIZATION;

AGED; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; ISOMERISM; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030823230     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19971001)33:2<133::AID-PROS7>3.0.CO;2-L     Document Type: Article

References (18)

1. Steiner MS: Review of peptide growth factors in benign prostatic hyperplasia and urologic malignancy. J Urol 1995;153: 1085-1096.
2. Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 1990;6:597-641.
3. Moses HL, Yang EY, Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 1990; 63:245-247.
4. Mori H, Maki M, Oishi K, Jaye M, Igarashi K, Yoshida O, Hatanaka M: Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia. Prostate 1990;16:71-80.
5. Merz VW, Arnold AM, Studer UE: Differential expression of transforming growth factor-β1 and β3 as well as c-Fos mRNA in normal human prostate, benign prostatic hyperplasia, and prostatic cancer. World J Urol 1994;12:96-98.
6. Steiner MS, Anthony CT, Metts J, Moses HL: Prostate cancer cells lose their sensitivity to TGFβ1 growth inhibition with tumor progression. Urol Oncol, in press.
7. Steiner MS: Transforming growth factor-β and prostate cancer. World J Urol 1995;13:329-336.
8. Barcellos-Hoff MH, Derynck R, Tsand ML, Weatherbee JA: Transforming growth factor-beta activation in irradiated murine mammary gland. J Clin Invest 1994;93:892-899.
9. Kim S-J, Park K, Koeller D, Kim KY, Wakefield LM, Sporn MB: Post-transcriptional regulation of human transforming growth factor-β1 gene. J Biol Chem 1992;267:13701-13707.
10. Eklov S, Funa K, Nordgren H, Olofsson A, Kanzaki T, Miyazono K, Nilsson S: Lack of latent transforming growth factor β binding protein in malignant, but benign prostatic tissue. Cancer Res 1993;53:3193-3197.
11. Timme TL, Yang G, Truong LD, Kadmon D, Park SH, Thompson TC: Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities. World J Urol 1995;13:324-328.
12. Truong LD, Kadmon D, McCune BK, Flanders KC, Scardino PT, Thompson TC: Association of transforming growth factor-β with prostate cancer: An immunohistochemical study. Hum Pathol 1993;24:4-9.
13. Steiner MS, Zhou Z, Tonb DC, Barrack ER: Expression of transforming growth factor-β1 in prostate cancer. Endocrinology 1994;135:2240-2247.
14. Glynne-Jones E, Harper ME, Goddard L, Eaton CL, Matthews PN, Griffiths K: Transforming growth factor beta 1 expression in benign and malignant prostatic tumors. Prostate 1994;25:210-218.
15. Ikeda T, Lioubin MN, Marquardt H: Human transforming growth factor type beta-2: Production by a prostatic adenocarcinoma cell line, purification and initial characterization. Biochemistry 1987;26:2406-2410.
16. Madisen L, Webb NR, Rose TM, Marquartd H, Ikeda T, Twardzik D, Seyedin S, Purchio AF: Transforming growth factor-β2: cDNA cloning and sequence analysis. DNA 1988;7:1-8.
17. Knabbe C, Klein H, Zugmaier G, Voigt KD: Hormonal regulation of transforming growth factor-β2 expression in human prostate cancer. J Steroid Biochem Mol Biol 1993;4:137-142.
18. Merz VW, Miller GJ, Krebs T, Timme TL, Kadmon D, Park SH, Egawa S, Scardino PT, Thompson TC: Elevated transforming growth factor-β1 and β3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate. Evidence for a paracrine role during progression. Mol Endocrinol 1991;5:503-513.